RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES
https://doi.org/10.20996/1819-6446-2009-5-3-25-30
Abstract
Aim. To study erectile dysfunction prevalence among out-patients with arterial hypertension (HT) and/or coronary heart disease (CHD) as well as to study risk factors of erectile dysfunction.
Material and methods. The anonymous poll was carried out among 103 male patients with HT and/or CHD. General information about patient, medical history, treatment was analyzed. All patients were examined by cardiologists. Erectile function was assessed with The International Index Erectile Function (IIEF) questionnaire.
Results. 86 (84%) questionnaires were returned. 62 (72%) patients from 86 responding had erectile dysfunction. Age, blood pressure level, abdominal obesity, beta-blocker therapy and chronic heart failure affected erectile function.
Conclusion. The erectile dysfunction was common disorder among male patients with HT and/or CHD. Early erectile dysfunction diagnosis, prevention and therapy are necessary to provide high level of compliance in patients with cardiovascular diseases.
About the Authors
E. V. Minakov
Voronezh State Medical Academy named after N.N.Burdenko
Russian Federation
Studencheskaya ul. 10 Voronezh, 394000
Russian Federation
Studencheskaya ul. 10 Voronezh, 394000
R. A. Khokhlov
Voronezh Regional Clinical Hospital № 1
Russian Federation
Russian Federation
Interregional Cardiology Center
Moskovsky prosp. 151-2, Voronezh, 394082
T. N. Kuznetsova
Voronezh Regional Clinical Hospital № 1
Russian Federation
Russian Federation
Interregional Cardiology Center
Moskovsky prosp. 151-2, Voronezh, 394082
Y. V. Popovskaya
Voronezh Regional Clinical Hospital № 1
Russian Federation
Russian Federation
Interregional Cardiology Center
Moskovsky prosp. 151-2, Voronezh, 394082
D. V. Snustikov
Voronezh Regional Clinical Hospital № 1
Russian Federation
Russian Federation
Interregional Cardiology Center
Moskovsky prosp. 151-2, Voronezh, 394082
E. E. Tsareva
Voronezh Regional Clinical Hospital № 1
Russian Federation
Russian Federation
Interregional Cardiology Center
Moskovsky prosp. 151-2, Voronezh, 394082
V. I. Yarliykova
Voronezh Regional Clinical Hospital № 1
Russian Federation
Russian Federation
Interregional Cardiology Center
Moskovsky prosp. 151-2, Voronezh, 394082
N. M. Akhmedzhanov
State Research Center for Preventive Medicine of Rosmedtechnology
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Russian Federation
Petroverigsky per. 10, Moscow, 101990
References
1. Solomon H., Man J.W., Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003;89(3):251–3.
2. Roth A., Kalter–Leibovici O., Kerbis Y. et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1412 Israeli men. Clin Cardiol 2003;26(1):25–30.
3. Wabrek A. J., Burchell R. C. Male sexual dysfunction associated with coronary artery disease. Arch Sex Behav 1980;9(1):69-75.
4. Agarwal A., Jain D. C. Male sexual dysfunction after stroke. J Assoc Physicians India 1989;37(8):505-7.
5. Virag R., Bouilly P., Frydman D. Is impotence an arterial desease? A study of arterial risk factors in 440 impotense men. Lancet 1985;1(8422):181-4.
6. Nusbaum M.R. Erectile dysfunction: prevalence, etiology, and major risk factors. J Am Osteopath Assoc 2002;102(12 Suppl 4):S1–6.
7. Greenstein A., Chen J., Miller H. et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997;9(3):123–6.
8. Kirby M., Jackson G., Betteridge J., Friedli K. Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001;55(9):614–8.
9. Slag M.F., Morley J.E., Elson M.K. et al. Impotence in medical clinic outpatients. JAMA 1983;249(13):1736–40.
10. Fogari R., Zoppi A. Effects of antihypertensive therapy on sexual activity in hypertensive men. Curr Hypertens Rep 2002;4(3):202–10.
11. Ralph D., McNicholas T. UK management guidelines for erectile dysfunction. BMJ 2000;321(7259):499–503.
12. Ko D.T., Hebert P.R., Coffey C.S. et al. Beta–blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002;288(3): 351-7.
13. Арабидзе Г.Г., Арабидзе Гр. Г. Антигипертензивная терапия и половая функция у мужчин. Клиническая фармакология и терапия 1999;(3):49–52.
14. Bedell S.E., Duperval M., Goldberg R. Cardiologists’ discussions about sexuality with patients with chronic coronary artery disease. Am Heart J 2002;144(2):239–42.
15. Ferrario C.M., Levy P. Sexual dysfunction in patients with hypertension: implications for therapy. J Clin Hypertens (Greenwich) 2002;4(6):424–32.
16. Шальнова С. А., Деев А. Д., Карпов Ю. А. от имени участников программы ПРЕМЬЕРА. Артериальная гипертония и ИБС в амбулаторной практике врача-кардиолога. Кардиоваскулярная терапия и профилактика 2006;5(2):73-80.
17. Rosen R.C., Riley A., Wagner G. et al. The International Index of Erectile function (IIEF): a multidimensional scale for the assessment of erectile dysfunction. Urology 1997;49(6): 822–30.
18. DeBusk R., Drory Y., Goldstein I. et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000;86(2A):62F–68F.
19. Реброва О. Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.: Медиа Сфера; 2002.
20. Национальные Рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр). Журнал Сердечная недостаточность 2007;8(1):4-41.
21. Николаев А.Н. Лозартан уменьшает половую дисфункцию при гипертонии. РМЖ 2001;9(13–14):590–2.
22. Котовская Ю. В., Кобалава Ж. Д. Артериальная гипертония: ключи к диагностике и лечению. М.: ГЭОТАР; 2007.
23. Braun M., Wassmer G., Klotz T. et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000;12(6):305-11.
24. Гамидов С.И., Иремашвили В.В. Эректильная дисфункция и сердечно-сосудистые заболевания: новый взгляд на старую проблему. Кардиоваскулярная терапия и профилактика 2006;5(6):123-8.
25. Верткин А.Л. Эректильная дисфункция в практике врача-кардиолога. РМЖ 2003; 11(19):1107–11.
26. Fogari R, Zoppi A, Poletti L, et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001;14(1):27-31.
Review
For citations:
Minakov E.V., Khokhlov R.A., Kuznetsova T.N., Popovskaya Y.V., Snustikov D.V., Tsareva E.E., Yarliykova V.I., Akhmedzhanov N.M. RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES. Rational Pharmacotherapy in Cardiology. 2009;5(3):25-30. (In Russ.) https://doi.org/10.20996/1819-6446-2009-5-3-25-30
Views:
792
Email this article 